biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Monkeys

<< Previous

Bullboard Posts

Next >>

Comment by DeadMonkeyon May 04, 2023 11:25am

61 Views

Post# 35430102

RE:Monkeys

your comment is short-sighted.-the study was done in healthy animals on purpose. it showed xb3 crossed bbb in nhp's validating all of the rodent stufies. showing it is capable of doing so.there is so much more to it. you really have no clue what you are talking about.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale